Financial Summary (All financials)
| In millions, except per share items | Feb-28-22 | Feb-28-21 | Feb-29-20 | Feb-28-19 | Feb-28-18 | Feb-28-17 | Feb-29-16 | Feb-28-15 |
| Revenues | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | -32.5% | 69.6% | | | | | | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | 100.0% | | | | | |
| Selling, general and administrative | | | | | | | | |
| Research and development | 0.5 | 1.0 | 1.9 | 0.8 | 3.0 | 1.1 | 0.9 | |
| General and administrative | 0.3 | 0.5 | 0.9 | 0.5 | 0.5 | 0.4 | 0.2 | 0.0 |
| EBIT | -0.8 | -1.4 | -2.8 | -1.3 | 0.0 | 50.6 | 4.6 | 0.0 |
| EBIT margin | -1540.3% | -1744.4% | -5881.2% | | | | | |
| Pre-tax income | -0.8 | -1.5 | -2.8 | -1.3 | -3.5 | 42.3 | 1.1 | 0.0 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Net income | -0.8 | -1.5 | -2.8 | -1.3 | -3.5 | 42.3 | 1.1 | 0.0 |
| Net margin | -1561.8% | -1854.9% | -5985.8% | | | | | |
| |
| Diluted EPS | ($0.42) | ($0.76) | ($1.61) | ($0.01) | ($0.03) | $0.35 | $0.01 | $0.00 |
| Shares outstanding (diluted) | 2.0 | 2.0 | 1.7 | 135.2 | 123.1 | 120.0 | 120.0 | 5.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|